SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-006744
Filing Date
2023-03-06
Accepted
2023-03-06 08:50:10
Documents
14
Period of Report
2023-03-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41068
2 ex99-1.htm EX-99.1 60217
3 ex99-1_logo.jpg GRAPHIC 6406
  Complete submission text file 0001493152-23-006744.txt   294541

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aim-20230306.xsd EX-101.SCH 3227
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aim-20230306_lab.xml EX-101.LAB 34916
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aim-20230306_pre.xml EX-101.PRE 22790
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3653
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 23707698
SIC: 2836 Biological Products, (No Diagnostic Substances)